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the technome - A predictive 
internal calibration Approach for 
Quantitative imaging Biomarker 
Research
Alexander Mühlberg1*, Alexander Katzmann  1,6, Volker Heinemann3,4, Rainer Kärgel1, 
Michael Wels1, oliver taubmann1, félix Lades1, thomas Huber2, Stefan Maurus2, 
Julian Holch3,4, Jean-Baptiste faivre5, Michael Sühling1, Dominik nörenberg2,7 & 
Martine Rémy-Jardin5,7
the goal of radiomics is to convert medical images into a minable data space by extraction of 
quantitative imaging features for clinically relevant analyses, e.g. survival time prediction of a 
patient. one problem of radiomics from computed tomography is the impact of technical variation 
such as reconstruction kernel variation within a study. Additionally, what is often neglected is the 
impact of inter-patient technical variation, resulting from patient characteristics, even when scan and 
reconstruction parameters are constant. In our approach, measurements within 3D regions-of-interests 
(Roi) are calibrated by further Rois such as air, adipose tissue, liver, etc. that are used as control regions 
(cR). our goal is to derive general rules for an automated internal calibration that enhance prediction, 
based on the analysed features and a set of CRs. We define qualification criteria motivated by status-
quo radiomics stability analysis techniques to only collect information from the cRs which is relevant 
given a respective task. these criteria are used in an optimisation to automatically derive a suitable 
internal calibration for prediction tasks based on the cRs. our calibration enhanced the performance for 
centrilobular emphysema prediction in a copD study and prediction of patients’ one-year-survival in an 
oncological study.
Technical variation poses a problem for radiological quantification of biological structures – in particular in terms 
of morphological tissue characteristics. In computed tomography (CT), for instance, a change in scan protocol 
or reconstruction method may considerably vary observable texture in the acquired 3D image series and thus 
texture quantifying features. Therefore, status-quo radiology is mainly a qualitative effort in the sense that it relies 
on the radiologists’ experience who can usually integrate above-mentioned technical variation intuitively in their 
diagnosis. Correspondingly, most radiological tomographic reconstruction methods, also in magnetic resonance 
imaging (MRI), are optimised for qualitative, not quantitative, assessment. For the successful application of radi-
omics, high-throughput and high-content screening of standard-of-care medical images, or quantitative imaging 
biomarkers (QIB) research in general, though, this technical variation poses a much larger problem. Analysed 
features can be very sensitive to the impact of technical variation. That is, a feature can be strongly affected by a 
technical characteristic, e.g., by a slight streak artifact barely recognisable for the human reader. It is hence worth 
striving for appropriate techniques to reduce this negative impact of technical variation on extracted features 
and, moreover, to make subsequent statistical analysis resistant to such effects. In the scientific literature, mainly 
the impact of trivially reducible technical variation on features is analysed, e.g., by the Quantitative Imaging 
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Biomarker Alliance (QIBA)1. In CT, this variation results from varying scan and reconstruction parameters or 
from acquisitions with entirely different scanners. For the most part, it is thus reducible by simply setting the asso-
ciated parameters to constant values. Accordingly, the QIBA’s main goal is the optimisation and standardisation of 
scan protocols. This is often attempted by impact analysis of acquisition parameters or scanner types2–7.
Technical variation can however result from interaction between the image acquisition and individual patient 
characteristics, too, yielding both inter-patient noise and artifact variation. In CT, a corpulent patient with a larger 
cross-section will usually have a higher noise level within his body than a slimmer patient. This effect appears 
despite constant scan parameters as less quanta arrive at the detector. Another example is beam hardening that is 
stronger if the cross-section of the patient is larger: photons in the center then have a higher average energy than 
in the periphery. As this kind of technical variation can occur although extrinsic factors are kept constant, we call 
it the non-(trivially-)reducible technical variation. While regular technical variation results from variation of e.g. 
voxel spacing, reconstruction kernel or slice thickness, non-reducible technical variation is a result of variation of 
patient geometry and/or attenuation characteristics and expresses in noise or artifact variation, such as cupping 
artifacts. While scientists in the field of image acquisition and image reconstruction deal with such non-reducible 
technical variation decreasing its qualitative influence with advanced techniques (e.g. via tube current modula-
tion8), it is not known which impact non-reducible technical variation has on derived quantitative features, e.g. 
radiomics, in relation to the examined biological or pathological variation.
The impact of technical variation on the evaluation of scientific questions was initially marked by Leek9. He 
has shown that for laboratory experiments the measurements were correlated with e.g. the date of the experiment. 
He therefore used the word surrogate as a feature indicative for the technical variation as the date or the humidity 
of the laboratory. He describes different data-driven procedures to identify such surrogates. Fortin expanded 
this concept and used the cerebrospinal fluid in MR images as a so-called control region (CR, for technical varia-
tion)10. A singular value decomposition (SVD) of the CR cohort variation is used to determine the main technical 
variation in the cohort. He then decomposed the voxel intensity distribution of the brain into an impact of the 
biological label and an impact of the main technical variation by a least-squares fit. Finally, the intensity distri-
bution is adjusted for the fitted technical variation, which is why the method is called Removal of of Artificial 
Voxel Effect by Linear Regression (RAVEL). ComBAT11 is also an older technology from genomics that found 
attention recently as the method was capable of stabilising radiomics features for technical variation resulting 
from different imaging protocols12. In this method, a feature is decomposed into an additive and an multiplicative 
imaging protocol effect. The effects are then estimated by an empirical Bayes fit and removed from the feature by 
subtraction and division. These are statistical methods, i.e. a calibration is learned on the same data as it is applied 
and their main focus is the stabilisation of intensity distributions or features with regards to technical variation.
Surrogate features encoding technical variation also play a crucial role in our approach. Although technical 
variation can completely falsify a statistical analysis, in-house experiments show that machine learning classifi-
ers such as a random forest can to a certain degree automatically learn and therefore compensate for technical 
variation when predicting a label if enough data and features are available. Our goal is therefore to automatically 
qualify and subsequently select surrogates from CRs to enhance prediction tasks associated with the actual target 
regions. We focus on predictive calibration with regards to a label in contrast to the statistical standardisation 
found in the literature. Whereas statistical standardisation learns the calibration on the same data as it is applied, 
we apply the calibration to unseen data.
Method
As mentioned above we assume that the impact of both types of considered technical variation is not only pres-
ent in a target region-of-interest (ROI), but also in a CR, a region inside the body which should ideally show 
only little inter-patient biological variation. The CR is thus assumed to store a patient-specific fingerprint of the 
inter-patient technical variation. Ideally, a CR should be close to a ROI in order to reduce the influence of spatially 
non-uniform noise and artifact distributions. Chambers of in-scan phantoms, which often serve as CRs, addi-
tionally placed next to the patient at scan time are particularly subject to this kind of inhomogeneity13. Besides, 
most clinical data is not acquired with in-scan phantoms. Our approach therefore merely relies on CRs that are 
naturally part of the imaging data to be processed. Regarding patient cohorts, the fingerprints of both regions, 
ROI and CR, induce an inter-patient correlation of biological and technical image information. For the sake of 
robustness, we extract surrogates from a multitude of CRs. We assume the entirety of surrogates over all CRs 
to contain the essential reducible and non-reducible technical information for relational quantification such as 
shown in Fig. 1. However, not all CRs and especially not all surrogates extracted from CRs are indeed suitable to 
represent technical variation. Thus they need to be qualified for this purpose, which we will describe later.
Reducible technical variation is termed TR and non-(trivially-)reducible technical variation TNR. We call the 
entirety of features in a ROI a radiome = .. ∈∈r r r( ) : ( , , )ij j R ij iM
M  with patient index i and feature index j for a 
total of M extracted features. The relevant clinical annotation (or label) for patient i is termed bi. The general task 
of personalised medicine within imaging science is the generation of classification models which predict 
(machine learning) or explain (statistics) bi by analysing ∈ ∈r( )ij i P j R,  for the analysed patients P. This allows to 
design decision-support algorithms = ∈b̂ f r(( ) )i ij j R
clf , where R is the set of used features. We define S as the set of 
used surrogates. Accordingly the surrogate space is termed sil for l ∈ S.
explicit and implicit calibration in literature: stabilisation and predictive mode. To understand 
the dichotomy we will introduce in our calibration, we first have to explain the case separation of explicit and 
implicit calibration in the literature. It is a well-known problem that a calibration method that maximises the sta-
bility against technical variation may not be the method that enables optimal classification or prediction14–16. This 
is based on the fact that the focus of a calibration for the latter must lie on the discriminative part of the biological 
variation – and not the overall stability. We thus see two different operational modes of a calibration: predictive 
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mode and stabilisation mode. The stabilisation mode yields the stabilised radiome only, while the predictive mode 
works with respect to the final prediction task.
The stabilisation mode is used to maximise the amount of information invariant to technical variation. RAVEL 
and ComBat use this mode as they explicitly remove the technical variation from the features. They first decom-
pose the feature into technical and biological covariates. This happens by a linear fit. RAVEL fits the intensity 
distribution by the singular vectors of the CR intensities as determined by a SVD. The decomposition of RAVEL 
for the voxel →v  is,
∑β β β→ = + + → .I v b I CR v( ) SVD ( ( ( )))
(1)i b i k
N
k k i0
This fit yields the estimates β̂0, β̂b and β = …ˆ k N, 1,k . The standardised intensity distribution then is,
∑β β= −



+



.∗
→ → →ˆ ˆI v I v I CR v( ) ( ) SVD ( ( ( )))
(2)
i i k
k
N
k k i
Translating the RAVEL principle from intensity distributions to features, we arrive at,
∑β β= −



+



.∈ ∈ˆ ˆ
⁎r r sSVD (( ) )
(3)
ij ij
k
N
k k il i P l S0 ,
We term this approach RAVEL-like. Alternatively, the impact of covariates can linearly be removed after 
decorrelating them to select the most important ones: With ANCOVA, the feature can be decomposed into covar-
iates17. Then a GLM fits the deviation of the feature from a fixed value by the deviation of covariates from their the 
average value within the cohort. By using surrogates as covariates this becomes ∆ = − ∈s s savg (( ) )il il i il i P . In anal-
ogy to this covariate adjustment, the impact of qualified surrogates on the feature can be estimated by a linear fit,
∑β β= −



+ ∆


∈
ˆ ˆ⁎r r s
(4)
ij ij j
l S
lj il0
for surrogates ∈s l S,il  and with the calibrated feature value 
⁎rij  for j ∈ R. We see that the general form of the 
explicit calibration is,
= − .⁎r r g (5)ij ij j
reg
In RAVEL and ANCOVA, the function gj
reg takes a linear form and is parametrised by singular vectors or 
covariates. The regression coefficients are determined by a decomposition of the feature and a linear fit. This 
approach however is per design extensible for a machine learning-based calibration procedure. The feature can of 
course also be fitted, or trained, by a machine learning model. For instance, gj
reg  could be a random forest regres-
sion gj
RF that predicts the deviation of the feature from a fixed value by the deviation of the surrogates from their 
mean. Subsequently, the predicted value can be subtracted from the feature value of the test data. This approach 
Figure 1. A tumour ROI (a) is internally calibrated by relating it to texture measurements in CRs such as 
adipose tissue (b) or air (c). It is assumed that TR and TNR are present in ROI and CRs.
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can be seen as a machine learning generalisation of the linear covariate adjustment. We will need this analogy 
later on for the validation of our method.
The predictive mode, on the other hand, assumes that not the whole image information needs to be stabilised 
for technical variation, but solely the image information that is needed for the classification task. Thus the invar-
iance is optimised for the diagnostic relevant information. This approach is motivated by Leek9, who suggests 
to incorporate suitable surrogates for technical variation in the classification process. He also points out that 
it is important to identify suitable surrogates. In the field of laboratory experiments, surrogates such as ‘date of 
experiment’ or ‘laboratory personnel’ can be identified by a data-driven analysis. We, however, want to search 
CRs for suitable surrogates. We term the incorporation of these surrogates the predictive calibration mode. The 
classification process to predict the label bi for patient i then becomes,
= ∈ ∈b̂ f r s(( ) , ( ) ), (6)i ij j R il l S
clf
where ∈s( )il l S are surrogate values for the patient i. The radiome is implicitly calibrated within the classification 
process by incorporating the qualified surrogates that have been shown to interact with the radiome technically 
and linearly.
Naturally, not all available surrogates should be used for explicit or implicit calibration, but only a qualified 
subset that is indeed suitable to calibrate the given features. Using all accessible surrogates without any qualifi-
cation is termed a naive approach. Given enough data a classifier can to some degree compensate for technical 
variation even in a naive approach, however, we expect an increase in stabilisation and especially predictive per-
formance when the surrogates are qualified for the given features which they shall explicitly or implicitly calibrate.
We term the refined classifier ∈ ∈f r s(( ) , ( ) )ij j R il l S
clf
q  based on features and qualified surrogates Sq ‘technome 
predictive mode’. The set of regression models ∈g j R,j
reg  to explicitly calibrate a feature based on qualified surro-
gates for the respective feature is termed ‘technome stabilisation mode’. The technome can therefore have two 
modes, specialising on stabilisation or prediction. We now describe how the surrogates are qualified and the 
technome is constructed based on surrogate qualification for the respective mode.
technome construction as a Model-Based optimisation
A diagram that gives an overview of this section is shown in Fig. 2. As explained above, used surrogates should not 
only be qualified for a suitable calibration but also enhance prediction. We denote a qualification score of a surrogate 
l ∈ S for the feature j ∈ R as qjl. Surrogates are qualified by in vivo assessment qjl
inVivo, in silico tests qjl
inSilico, phantom 
tests qjl
inVitro and also for statistical reasons qjl
orthog. An exhaustive explanation and rationale of our qualification crite-
ria can be found in the Supplementary Material (A.). Pseudo code of the method is found in Supplementary Material 
(B.). As the relevance of the different surrogate qualification criteria for the technome construction process is 
unknown, we have to introduce free weighting parameters θ θ θ θΘ = { , , , }inVivo inSilico inVitro orthog  which we deter-
mine on training data. We therefore define a loss function that has to be minimised,
Θ = Θ + Θ .L L L( ) ( ) ( ) (7)train calib
The performance for the respective task on the training data is introduced as Ltrain. In predictive mode it should 
be a classification performance metric e.g. an Area-Under-Curve of the receiver-operating characteristic (AUC) 
for the given label, in stabilisation mode it should ideally be a metric that quantifies the stabilisation performance. 
For the technome stabilisation mode, the training loss may be introduced as the variance of the feature deviation 
from the cohort mean that can be explained by the surrogates’ deviation of the cohort mean. For the technome 
predictive mode, the training loss may be the predictive performance in a 10-fold cross-validation (CV) on the 
training data in case of a machine learning procedure. In case of a statistical classifier such as the logistic regres-
sion, we can simply use the discriminative AUC of the classifier on the training data.
We now calculate a qualification score Qjl for each of the surrogates l ∈ S for each of the features j ∈ R of the 
radiome. We define the qualification score for surrogate l for the feature j and the parametrisation Θ as,
Figure 2. Overview of the method.
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θ θ θ θΘ = + + + ∈ ∈ .Q q q q q j R l S( ) , , (8)jl jl jl jl jl
inVivo inVivo inSilico inSilico inVitro inVitro orthog orthog
The set of qualified surrogates to calibrate the respective feature of the radiome is then defined as all surrogates 
with a qualification score higher than an arbitrary value of Qmin = 1.0. The weights Θ control which surrogates are 
selected for the internal calibration.
= ∈ | Θ > ∈ .ΘS l S Q Q j R{ ( ) , } (9)R
q
jl min,
For each feature j ∈ R of the radiome a subset of qualified surrogates is determined. By penalising large weights 
Θ, only surrogates with sufficiently high qualification values are selected by Eq. 9, thus semantically constraining 
the available image information used for calibration. The crucial point is now to enforce an internal calibration of 
the features by introducing the calibration loss as,
∑α θΘ = −





θ∈Θ
L ( ) / ,
(10)
calib
in which a higher qualification of the surrogates translates to a lower value of Lcalib. The design parameter α is 
introduced to find a reasonable tradeoff between the used performance metric on the training data and the 
enforced internal calibration. A Bayesian optimisation process18 is used to determine the weights of the semantic 
constraints Θ that minimise the combined loss for training and qualification = +L L Ltrain calib on the experi-
mental data similar to systems-biology model building approaches19,
Θ = + .
Θ
L Largmin( )
(11)train calib
The minimisation of L is achieved by Bayesian optimisation on training data. This determines the chosen 
weights Θ which in turn construct the technome.
We expect a higher predictive and stabilisation performance for unseen data when the surrogates have higher 
qualification and indeed internally calibrate the analysed radiome.
As a side effect, the technome can also be read out to discover new insights of feature stability in general (sta-
bilisation mode) or technical impact on diagnosis (predictive mode). The qualification criteria scores Qjl on the 
one hand help to determine suitable surrogates, on the other hand they also determine feature stability in vivo, 
in vitro and in silico. If many qualified surrogates can be found for a feature even for low values of Θ, the feature 
is non-robust. Finally, the weights Θ can help to explore whether either phantoms, simulations or associations in 
real data are most important to identify a suitable internal calibration that enhances predictive performance. The 
importance of different qualification criteria is to the best of our knowledge not yet analysed.
Validation Strategy
A diagram that gives an overview for this section is shown in Fig. 3. We employ a validation scheme similar to that 
of RAVEL10 that assesses if a calibration increases reproducibility of already shown associations between features 
and biological labels. For this purpose, we use two signatures that were often shown to be predictive for their use 
case: the Aerts signature20 for patient survival prediction in oncology and the low-attenuation area (LAA) signa-
ture consististing of LAA910 and LAA950 for emphysema assessment21. For the Bayesian optimisation needed to 
Figure 3. Overview of the validation strategy.
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construct the technome, we integrated an established Python implementation22 in our pipeline. The acquisition 
function ‘upper confidence bound’, 8 initial seeds, 500 iterations and a Kappa of 5 as tradeoff between ‘exploration’ 
and ‘exploitation’ were chosen. An overview of all conducted experiments for stabilisation and predictive mode is 
shown in Table 1. Analyses were conducted with R packages (version 3.3.2, www.R-project.org) and scikit-learn23.
Benchmark methods and train-test split. We compare the performance in technome stabilisation and 
predictive mode with the RAVEL-like approach and the naive approach, i.e. using all surrogates without any qual-
ification criteria, as introduced above.
As a first test we compare the technome performance with a naive approach. As explained above a naive 
approach uses Eq. 5 or 6 respectively with all available surrogates without constrainining them. It is assessed 
whether the classifier or regressor can identify the relevant surrogates by themselves without additional quali-
fication criteria. We test two cases for the stabilisation and prediction: a simple linear model f GLM or g GLM and 
a more complex, non-linear random forest classification, f RF, or regression, gRF, model. To minimise redundant 
surrogates for the naive linear approach, surrogates are decorrelated via minimum redundancy maximum rel-
evance (mRMR) algorithm24,25 and finally regularised by best subset feature selection according to the Akaike 
information criterion (AIC) to yield the set of used surrogates S.
The RAVEL-like approach uses the principal components of all available surrogates and uses formula 3 for the 
explicit stabilisation. For the predictive mode, the principal components are incorporated in the classifier. The 
Study type Task Data TR TNR Surrogates Features Technome Mode
Phantom Feature Stabilisation
103 CT Scan 
protocols for 
phantom
X X
PyRadiomics 
features in CRs 
air, adipose 
tissue, liver, 
trachea, spleen, 
heart, aorta
Aerts signature in 
phantom ‘liver-
tumours’
Stabilisation
COPD
CLE Prediction 676 lung 
parenchyma on CT
X LAA signature in 
parenchyma
Predictive
CLE SSD X Predictive
mCRC
1-ys Prediction 686 liver tumours 
on CT
X X
Aerts signature in 
liver tumours
Predictive
X X
1-ys SSD X X Predictive
Table 1. Overview of all experiments. Shown are the clinical field, task, used data, technical variation within 
the data, i.e. non-reducible TNR or also reducible TR, used surrogates, features and technome mode. CLE: 
centrilobular emphysema, 1-ys: one-year-survival.
Validation Scheme
Technome Computation and 
Training Set Test Set
10-fold CV 9/10 1/10
SSD 1/5 4/5
Table 2. Validation schemes and the ratio of used data for training and test set.
Figure 4. Lung phantom (left) and liver-lesion phantom (right) with CRs air (magenta) and ‘adipose tissue’ 
(yellow).
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principal components of the CR’s surrogates are determined via SVD. Principal components are collected until 
they explain 95% of the variance of the training data.
For technome predictive or stabilisation mode, we only assess linear approaches f GLM and gGLM respectively. By 
concept, we explicitly enforce a linear calibration with the inVivo and inSilico qualification and expect a potential 
advantage to use a regularised, interpretable and statistically valid model on training data.
To test the stabilisation or prediction performance on unseen data, a 10-fold CV is used. Therefore, the data 
is split in training and test data, where the ratio of train to test data is 9:1. The training data is used to qualify the 
surrogates and optimise the weights Θ. This yields the technome stabilisation or predictive mode, i.e. the regres-
sion model for explicit feature calibration, gGLM, or the refined classifier for the medical label, f GLM. The models 
are then applied for the unseen test data and the predictive or stabilisation performance is assessed. As very often 
in clinical scenarios only a small number of patients can be collected to detect the effect of a drug etc., the per-
formance of the method in the small sample setting is assessed. We therefore choose the ratio of train to test data 
as 1:4 and term this scenario small sample detectibility setting (SSD) (Table 2). Both train-test split scenarios are 
summarised in Table 2.
phantom dataset - feature stabilisation. To validate the technome stabilisation mode, 103 CT images of 
a liver-lesion phantom26 acquired with a Siemens Somatom Zoom Scanner are analysed (Fig. 4, right). The images 
were acquired with a variety of scan and reconstruction parameters. Varied parameters are e.g. kvp, mAs, slice 
thickness, voxel size. The 3 texture features of the Aerts signature are extracted within a ‘tumour-like’ ROI and the 
844 PyRadiomics27 features are used as surrogates S for the CRs air and ‘adipose tissue’. The ROIs are segmented 
by a semi-automated algorithm28.
The training loss is defined as variance R2 of feature j that is explained by gGLM for the current qualified surro-
gate selection averaged over all analysed features = −L R gavg (( ( ))j jtrain
2 GLM . For the calibration loss, only the 
qualification criterion qjl
inVivo is used for phantom scans, as no biological induced variation needs to be excluded. 
Therefore αθ= −Lcalib
inVivo with α = 0.1 is enforced. The labels of the scan and reconstruction parameters are not 
used for the task.
The stabilisation performance on the test data is assessed by the variance reduction of the procedure i.e. the 
difference of feature variance before and after calibration = − ∈
∈
⁎
Perf 1j
r
r
stabil var(( ) )
var(( ) )
ij i P
ij i P
. The performance is then 
determined as the average performance for all features j ∈ R, = avgPerf (Perf )j j
stabil stabil .
copD dataset – centrilobular emphysema prediction. To validate the technome predictive mode abil-
ity to enhance centrilobular emphysema prediction in the presence of only non-reducible technical variation, 676 
partly contrast-enhanced CT scans of 676 patients (age: 84.1 ± 14.8 y) each reconstructed with a soft (B36) and 
hard (B71) kernel, i.e. 1352 clinical CT images were acquired with a Siemens Somatom Force in Lille, France29. 
The cohort consists of patients with different symptoms of chronic obstructive lung disease (COPD). The study 
was approved by the local ethics commitee with waiver of the informed consent because CT examinations were 
part of routine clinical practice. Scan and reconstruction parameters are kept constant and only images recon-
structed with kernel B71 are analysed, therefore no reducible technical variation exists. Additionally, tube current 
modulation techniques8 CareDose and CareKV were used to guarantee consistent image quality and further 
minimise non-reducible technical variation.
Figure 5. Prototype used for parenchyma analysis. An example of a COPD patient is shown.
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The CRs air, trachea, adipose tissue, liver, heart, spleen and aorta segmented by an automated algorithm by 
Seifert et al.30. The lung parenchyma is segmented by an adaption of the deep learning segmentation of Yang et al.31  
(Fig. 5). As features R we analyse the LAA signature. The LAA signature consists of two clinical standard fea-
tures LAA910 and LAA95021. These features are commonly quantified to assess emphysema in clinical practice. 
Surrogates S are the 844 PyRadiomics27 features extracted in the CRs.
For the inSilico surrogate qualification qjl
inSilico, in silico variation was generated by superimposition of 
Gaussian, Rayleigh, Poisson and Gamma noise with 5 steps of monotonically increased noise each. For the 
inVitro surrogate qualification ql
inVitro, 16 CT images with varying scan and reconstruction parameters of the 
parenchyma in an anthropomorphic lung phantom32 (Fig. 4, left) were used.
The training loss is defined by the discriminative AUC of f GLM for the current selection of qualified surrogates 
on the training data LTrain = −AUC. The calibration loss is defined as α θ= − ∑θ∈ΘL /( )calib  with all qualification 
criteria and α = 0.2. The predictive performance is assessed as the AUC on the test data.
We compare the predictive performance of the technome for the hard kernel with the predictive performance 
of the LAA signature on the soft kernel. While a hard kernel is clinically considered inadequate for emphysema 
assessment due to larger inter-patient noise variation, we expect a predictive performance similar to the results 
for a soft kernel after calibration.
mcRc dataset – one-year-survival prediction. To validate the technome predictive mode ability to 
enhance one-year-survival prediction in the presence of non-reducible and also reducible technical variation, 
118 contrast-enhanced CT scans of 75 patients (age: 61.9 ± 11.4 y) with 686 analysed liver tumours acquired 
with a variety of scanners from different vendours (GE, Philips, Siemens, Toshiba) in Munich, Germany, are 
analysed33. The cohort consists of metastatic colorectal cancer (mCRC) patients with liver metastases. The study 
was approved by the local ethics commitee with waiver of the informed consent because CT examinations were 
part of routine clinical practice. Scan and reconstruction parameters show large variation i.e. reducible and 
non-reducible technical variation is present. Tumours were segmented by a semi-automated segmentation algo-
rithm28. The Aerts signature20 consisting of 4 features R is extracted from the tumour ROIs. Feature extraction 
and CR segmentation was conducted within a specialised radiomics framework34 (Fig. 6). Used surrogates S are 
the PyRadiomics features27 in the CRs air, trachea, adipose tissue, liver, heart, spleen and aorta again segmented 
by the algorithm of Seifert et al.30.
In silico variation for the calculation of qjl
inSilico was generated by superimposition of Gaussian, Rayleigh, 
Poisson and Gamma noise with 5 increasing steps each. For in vitro variation, 103 CT images of an anthropomor-
phic liver-lesion phantom26 (Fig. 4, right) with a variety of scan and reconstruction parameters were used.
Training and test loss are defined in analogy to the COPD dataset. For each fold, the tumours of a patient were 
either in the training or the test data and a split was not allowed. Again, the predictive performance is assessed as 
the AUC on the test data.
For comparison purposes, all PyRadiomics features are extracted in the tumours and entered in a random for-
est classifier to predict one-year-survival. This random forest is optimised by hyperparameter tuning on the train-
ing data. With this step, we can assess, whether our calibration outperforms a hyperparameter tuned classifier 
using an abundance of features within the ROI. Finally, we compare the predictive performance of our technome 
classifer with an advanced deep learning method. For more details regarding the deep learning architecture we 
refer to Katzmann et al.35.
Technome discovery – understand importance of qualification criteria and surrogates. Finally, 
it has to be analysed how qualification criteria are associated with the predictive performance. It is not clear 
whether an improvement of the predictive performance is really induced by an enforced internal calibration 
or simply by additional accessible biological information from the CRs. Therefore we have to assess whether 
qualification criteria indeed enforce an internal calibration. If this is the case, a higher qualification of surrogates 
should translate to a higher predictive performance. For the data presented above, each qualification criterion is 
inspected individually. For a first assessment, no loss is minimised as the goal is to analyse the association of qual-
ification criteria with predictive performance without emphasising a certain subspace of the weight space Θ. For 
the inspection of individual qualification critera, Qmin is varied to generate 100 samples starting with 4 random 
seeds. Also combinations of qualification criteria are assessed for their association with predictive performance.
In a second step, it is assessed whether the minimisation of the loss L with α = 0.1 and only one qualifica-
tion criterion, e.g. Lcalib = −0.1/θinVivo, yields acceptable predictive performance for each qualification criterion 
individually.
Finally, we read out the surrogates for calibration that yield the best performance for prediction of centrilob-
ular emphysema and one-year-survival. Potentially, the integration of these surrogates could enhance clinical 
models using the LAA or Aerts signature.
Results
phantom dataset – feature stabilisation. The results are shown in Fig. 7. The technome stabilisation 
mode gives a stabilisation performance [% variance reduction on test set] in a 10-fold CV (SSD) of 90.4% (91.8%). 
The RAVEL-like calibration yields 79.3% (76.7%) and the naive approach via GLM 74.7% (79.3%) or via random 
forest 76.7% (42.7%).
Apparently, 21 training datasets of the SSD setting were not sufficient for a complex calibration as observed by 
the stabilisation performance of the random forest regression with all surrogates.
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copD dataset – centrilobular emphysema prediction. The results are shown in Fig. 8. The predictive 
performance [% AUC on test set] in 10-fold CV (SSD) improved to 81.5% (74.4%) with technome predictive 
mode in comparison to GLM with 60.7% (60.0%) or random forest with 58.1% (59.1%). The technome was also 
superior to a RAVEL-like calibration of 70.4% (64.6%) and the naive approach via GLM with AUC of 70.8% 
(65.4%) or via random forest with 74.8% (67.0%).
Figure 6. Radiomics prototype34 for PyRadiomics feature and surrogate extraction. An example of a mCRC 
patient is shown.
Figure 7. Stabilisation performance [% variance reduction] in 10-fold CV (blue) and SSD (red) in the phantom 
study.
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As a comparison, the predictive performance of LAA signature on the soft kernel B36, which is the clinical 
standard for emphysema classification, was 76.6% (74.3%), which is numerically inferior to the technome cali-
bration for the hard kernel B71.
mcRc dataset – one-year-survival prediction. The results are shown in Fig. 9. The predictive perfor-
mance [% AUC on test set] in 10-fold CV (SSD) improved to 66.5% (53.4%) with technome predictive mode in 
comparison to GLM with 49.2% (49.9%) or random forest with 57.6% (49.3%). The technome was also superior to 
a RAVEL-like calibration of 58.9% (50.4%) and the naive approach via GLM with AUC of 49.9% (49.2%) or ran-
dom forest with 44.5% (43.3%). In the SSD scenario, no approach yielded an acceptable predictive performance. 
Apparently, the variation is too large to calibrate the signature with only few data.
For comparison, an advanced deep learning approach based on sparse autoencoder pre-training35 optimised 
for the same data achieved a performance of 71.1%. A radiomics approach with a random forest highly optimised 
by hyperparameter tuning using a nested CV and all PyRadiomics features calculated within the tumour ROIs 
achieves 56.8%.
Technome discovery – understand importance of qualification criteria and surrogates. In a 
first step, the association of predictive performance with each qualification criterion individually was inspected. 
Apparently, only inSilico and inVivo qualification show a deterministic behaviour for high qualifications. This is 
shown exemplarily for centrilobular emphysema and the inSilico qualification in Fig. 10 on the left. The inVitro 
and orthogonality qualification used alone, however, are not associated with predictive performance. This is 
shown exemplarily for the inVitro qualification on the right in Fig. 10. When the loss L is minimised, the tradeoff 
between training loss and calibration loss used in the Bayesian optimisation detects a point of good predictive 
performance for the inVivo and inSilico qualification within the deterministic area (‘Bayes’ in Fig. 10).
Therefore, we inspect the association of combined inVivo and inSilico qualification weights with predictive 
performance in Fig. 11. For the inspection of combined inVivo and inSilico weights, θ θΘ = { , }inVivo inSilico , 500 
random samples are drawn uniformly with fixed Qmin = 1.0. As can be seen in Fig. 11 the predictive performance 
is lower when all or many surrogates are used (underconstrained, UC) or no surrogate is qualified enough and 
thus no calibration is used (overconstrained, OC). Please note that surrogates with the highest qualification are 
found in direct border to the OC region and lower weights translate to a higher qualification of the surrogates as 
a consequence of Eq. 9. When only non-reducible technical variation is present, i.e. scan and reconstruction 
Figure 8. Predictive performance [% AUC] in 10-fold CV (blue) and SSD (red) for centrilobular emphysema 
prediction in the COPD study.
Figure 9. Predictive performance [% AUC] in 10-fold CV (blue) and SSD (red) for one-year-survival 
prediction in the mCRC study.
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parameters are constant within the study, the inSilico qualification appears to be more important for the predic-
tive performance as observed for centrilobular emphysema prediction in comparison to one-year-survival pre-
diction, where also reducible technical variation is present. A good predictive performance for one-year-survival 
was achieved when inSilico and inVivo qualification were combined. A high qualification according to both cri-
teria translates to a high predictive performance, while a larger weight for the inSilico qualification guarantees a 
higher predictive performance for emphysema presence.
In both studies a high qualification of surrogates according to the defined qualification criteria is associated 
with enhanced predictive performance. Though their individual inspection did not show any association with 
predictive performance, the additional integration of inVitro and orthogonality qualification still increased pre-
dictive performance numerically in comparison to the combined inVivo and inSilico qualification.
The surrogates that guaranteed the highest AUC on test data are shown in Table 3. The LAA signature is cal-
ibrated best by texture metrics within a cylindrical CR in the trachea, while the Aerts signature is calibrated by 
a combination of texture metrics in liver and heart. This could potentially be due to applied contrast injection 
variation that has to be calibrated.
Figure 10. Association of the inSilico (left) and inVitro qualification (right) with the predictive performance for 
centrilobular emphysema. For high qualification the inSilico qualification criterion leads to a higher correlation 
of predictive quality with qualification, while the correlation of the predictive performance rapidly decreases for 
lower qualification. The inVitro qualification criterion when used alone, however, shows no obvious association 
with predictive performance. Only for inVivo and inSilico qualification criteria, the Bayesian optimisation 
constructed a technome calibration with a good predictive performance (‘Bayes’).
Figure 11. Association of combined inVivo & inSilico qualification weights with the predictive performance 
[%AUC on test data] for centrilobular emphysema (left) and one-year-survival (right). Overconstrained (OC), 
i.e. no calibration, and underconstrained (UC) regions, i.e. also surrogates with low qualification are used, show 
lower predictive performance than models, where the analysed features were implicitly calibrated by highly 
qualified surrogates. Lower weights Θ translate to a higher qualification.
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Discussion
On CT images, all measurements should be seen as relative – a notion that is already accepted for bone mineral 
density measurements that are therefore calibrated by in-scan phantoms as seen, e.g., in the work by Kalender36. 
For bone mineral density, a calibration relates the measurements in a ROI to quantifications in the in-scan phan-
tom. A univariate feature analysis without calibration thus appears dubious in most other cases as well. However, 
a machine learning algorithm can to some degree automatically calibrate for technical variation when predicting 
a label. We also observed this effect in our COPD study, where a naive approach that incorporated all available 
surrogates from non-lung CRs improved the predictive performance from 60.7% to 74.8%. To assist the classifier, 
we integrated an internal calibration based on surrogate qualification criteria in the training process of the classi-
fier to enhance predictive performance. A feature signature indicative for the medical label is enhanced by addi-
tional incorporation of qualified surrogates. The qualification criteria for the surrogates stem from other sources 
of information usually used in radiomics feature stability analyses, such as phantom measurements, simulations 
but also best practices in statistics. For instance, our statistical qualification criterion enforces valid covariates to 
be used, as for a proper statistical assessment no interaction effect between the examined biological variable and 
the used covariate should occur. The introduced inSilico qualification criterion rewards the use of surrogates, 
when their association with the analysed feature in vivo can also be reidentified in simulation studies, which 
makes it highly unlikely that the association beween feature and surrogate is induced biologically. As in our case 
the technome classification uses a simple logistic regression model, the results can also be used for interpretable 
statistical assessment. The surrogates that are used within the model are appropriate for this task, as they have 
been shown to be suitable covariates by in vivo, in vitro, in silico, and orthogonality tests.
Our approach based on regularised models in which established imaging biomarker signatures are internally 
calibrated yielded better predictive performance than the signatures without calibration. Our models also outper-
formed conventional machine learning models with all available features and surrogates. This can be interpreted 
as an enhanced reproducibility of imaging biomarkers. Only an advanced deep learning approach35 that employs 
a sparse autoencoder for dimensionality reduction performed better to predict one-year-survival. However, deep 
learning lacks the interpretability and probably also the reproducibility of our approach. This is especially impor-
tant as the lack of interpretability and especially reproducibility37 is already recognised as a large problem, not 
only for clinical studies, where a significant result of a potential biomarker associated with a treatment can often 
not be reproduced in similar studies. While the Imaging Biomarker Standardisation Initiative (IBSI)38 adresses 
this problem by introducing unified feature definitions, the minimisation of technical variation remains a press-
ing issue.
First, the technome improved centrilobular emphysema prediction with a hard kernel and using the LAA 
signature from an AUC of 60.7% to 81.5%. Possibly, this could be of clinical value as a hard kernel was previ-
ously considered inadequate for emphysema assessment due to the inter-patient noise variation. The predic-
tion of emphysema based on LAA features only with a soft kernel even showed a slightly worse performance of 
77%. Second, by calibration, the Aerts signature to predict one-year-survival reproduced its expected predictive 
performance with an AUC of 66.5%. In the original study20 this signature yielded a concordance index, which 
Signature CR Qualified surrogates
Aerts signature
Grey Level 
NonUniformity
Heart WL_LHH_GLSZM_LargeAreaEmphasis
Liver GLSZM_SizeZoneNonUniformity, firstorder_Entropy
Trachea WL_LHL_GLRLM_GrayLevelNonUniformity, WL_HHL_GLSZM_LargeAreaHighGrayLevelEmphasis, WL_HLL_firstorder_Uniformity
Adipose Tissue GLCM_Idmn
Statistics Energy
Liver GLRLM_HighGrayLevelRunEmphasis, WL_LLL_firstorder_Entropy
Heart firstorder_Entropy
Air WL_HLH_firstorder_10Percentile
Grey Level 
NonUniformity HLH
Liver GLSZM_SizeZoneNonUniformity, GLCM_Imc2
Heart WL_HLH_GLSZM_ZoneEntropy, WL_LHH_GLSZM_LargeAreaEmphasis
LAA signature
LAA950
Trachea GLDM_GrayLevelVariance, LS_0_5_mm_3D_GLDM_DependenceNonUniformityNormalized, GLDM_DependenceNonUniformity, GLDM_LargeDependenceEmphasis
Air GLDM_LowGrayLevelEmphasis
Spleen LS_2_5_mm_3D_GLDM_DependenceVariance, GLDM_DependenceVariance
Aorta LS_3_5_mm_3D_GLDM_DependenceNonUniformityNormalized
LAA910
Trachea LS_3_5_mm_3D_NGTDM_Complexity, LS_0_5_mm_3D_GLDM_LargeDependenceEmphasis
Heart LS_3_5_mm_3D_GLDM_GrayLevelNonUniformity, LS_0_5_mm_3D_GLDM_DependenceNonUniformity, LS_0_5_mm_3D_GLDM_LargeDependenceEmphasis
Table 3. Technome discovery. The qualified surrogates that led to the best predictive performance for one-year-
survival (top) and centrilobular emphysema presence (bottom) are shown. CRs are ordered according to their 
explained variance of the respective feature.The sphericity of the Aerts was robust to technical variation and is 
thus omitted. Abbreviations for filters - LS: logSigma, WL: Wavelet. Further explanations about PyRadiomics 
classes’ nomenclature such as ‘GLSZM’ can be found in the original publication27.
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is a generalisation of an AUC, of 66–69% for unseen data. The prediction of one-year-survival based on the 
calibrated Aerts signature was superior in comparison to no calibration (49.2% via GLM and 57.6% via ran-
dom forest), an optimised radiomics approach that uses all PyRadiomics features within the tumours and a 
nested cross-validation process (56.6%), and even comparable to the most advanced ‘black-box’ deep learning 
approaches (71.1%). Using a naive approach and entering the signature and all available surrogates in a random 
forest classifier led to an predictive performance that was even worse compared to no calibration (44.5% vs. 
57.6%).
Despite not being our main focus, a second field of research was the explicit feature stabilisation in a phantom 
study. Although reducible technical variation can be read out via imaging protocol parameters, its information is 
sparse. For example the kernel is only a factor with no continuous parametrisation. This is also a limitation of the 
ComBat method, where for each imaging protocol a minimum number of cases must be available12. Therefore, 
it is not ensured that enough data for the respective imaging protocol can be collected. Also, a learned stabilisa-
tion, such as the deep learning approach by Jin39, does of course not work for unseen scan and reconstruction 
parameters. In our phantom study, the calibration is applied on unseen scan and reconstruction parameters and 
therefore not even one sample for each imaging protocol can be used to learn the calibration. ComBat does by 
design not work in this scenario. The technome parametrises reducible and non-reducible technical variation 
in a unified manner via qualified surrogates, while the information which scan and reconstruction parameters 
are employed is not used. We compared the technome stabilisation to an adaption of the well-known RAVEL 
method10, which is an advanced and well-performing MRI technique, that uses the singular vectors of variation 
in CRs to stabilise intensity distribution in MRI scans of the brain. The variance reduction performance of our 
method (90.4%) was numerically superior to RAVEL-like approach (76.3%) in the phantom study where object 
size, scan and reconstruction parameters were varied. This may be due to the fact that RAVEL uses the principal 
components of the CRs. Accordingly, each feature is calibrated by a selection from the same principal components 
of variation that are determined by a SVD of the CR’s surrogates. The voxel value, in our case the feature value, 
is then linearly adjusted for those principal components of variation. From our phantom experiments however, 
it appears that each feature needs a more specific calibration that can profit from a surrogate qualification. The 
principal components may not always be appropriate, a feature that is affected by a cupping artifact may not be 
properly calibrated if the cupping artifact is not expressed in the principal components. Again, the combination 
of a qualification criterion and a regularised model performed better than a naive approach using all surrogates 
(90.4% vs. 76.7% variance reduction).
The technome discovery indicates that technical variation can have an impact on features, even when scan 
and reconstruction parameters are kept constant within a study. One finding of our experiments is that the best 
predictive performance was achieved when surrogates are used that are qualified by the inVivo and the inSilico 
qualification metric. The inVivo qualification rewards when surrogates are used that are correlated with the fea-
ture. The inSilico qualification however analyses if the found correlation between feature and surrogate can be 
reproduced in simulations of technical variation. For constant scan and reconstruction parameters, simulations 
even appear necessary to qualify appropriate surrogates. The finding that a high qualification of the surrogates 
translates to a higher predictive performance explains the good prediction results that were achieved by introduc-
ing the calibration loss in both clinical studies. As the best predictive performance was observed for highly qual-
ified surrogates, it is very probable that the performance enhancement is due to the enforced internal calibration 
procedure and not due to integration of further biological information from the CRs. As a side effect we tested 
many different organs for imaging biomarkers, as the two studies were an exhaustive multi-organ analysis for 
COPD and mCRC. However, the addition of all available surrogates from all organs without qualification showed 
numerically inferior performance to the technome prediction. In the mCRC study, the integration even led to 
deterioration of predictive performance. We expect this to be a result of overfitting. Furthermore, the chosen CRs 
for calibration were plausible. The LAA signature measured in the parenchyma was internally calibrated by the 
representation of air within a cylinder in the trachea. For the mCRC data with contrast injection the technome 
used texture metrics within liver and heart. Interestingly, the technome chose the heart CR for calibration of con-
trast injection and not the aorta. This may be due to a more constant accumulation of contrast within the blood 
pool of the heart.
Our method has several limitations. The main limitation is the dichotomy of predictive and stabilisation mode. 
This case separation should ideally not be needed, as a perfect explicit calibration should also enhance predic-
tive performance without knowledge of the medical label. Second, we did not calculate Kaplan-Meier curves 
for survival prediction, which would allow a better comparison of the Aerts signature’s performance with the 
original study. An integration of the predictive mode within survival analysis would have needed further meth-
odological effort. Third, we used only simple simulations and qualified them with the similarity argument of the 
inSilico qualification criterion. However, we expect an increase in predictive and stabilisation performance when 
more complex simulations are applicable, which was not yet possible due to the large computation time for each 
case. Fourth, our method in its current form is very computation-intensive and time-consuming. Especially the 
inSilico qualification needs to synthetically manipulate the images to collect associations between features and 
surrogates. Fifth, although we qualify surrogates for a feature by a variety of criteria, it is still possible that the 
non-uniform noise and artifact distribution in CT images can lead to the selection of suboptimal surrogates. The 
noise texture in the ROI can still significantly differ from the technically-induced texture that is found in the CR. 
Finally, of course, more data and clinical prediction tasks, e.g. for COPD21, liver40, or muscle diseases41, are needed 
for further validation of the method. As a further proof of concept, the predictive performance of established 
imaging biomarkers should be reproduced in studies with larger technical variation.
In conclusion, we present a novel method that integrates qualification criteria for surrogates in the training of 
a classification or regression method leading to a predictive internal calibration. The method improved feature 
stabilisation in a phantom study, prediction of centrilobular emphysema in a COPD study and one-year-survival 
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in mCRC study. The analysed studies indicate that the identification of surrogate qualification criteria and their 
integration in the training process of a prediction model is a promising field of research.
In the future, we plan to combine the surrogate qualification with ComBat and deep learning. For the deep 
learning variant, the calibration loss could be included as a regularisation term that controls the incorporation 
of CRs in the classification process. For ComBat, the substitution of the imaging protocol by qualified surrogates 
seems to be an interesting option.
Data availability
The relevant data supporting the findings are available within the article. The clinical study data are available from 
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